Should Sanofi recruit Smith & Nephew's French CEO to replace Viehbacher?

Olivier Bohuon, the CEO of artificial hip and knee maker Smith & Nephew ($SNN), may have a leg up over other potential candidates to take the reins of drugmaker Sanofi ($SNY) after the firing of Chris Viehbacher last week. He has experience in pharma and has excelled at Smith & Nephew by moving it into new markets. Most importantly, he is French. Report

Suggested Articles

After showing Nucala could cut the rates of flares for hypereosinophilic syndrome, GSK is planning regulatory filings in 2020.

Mylan and Pfizer's Upjohn have a name for their pending merger: Viatris. Heard that before? So has Mylan, which owns a subsidiary with the same name.

Both IL-17A inhibitors have rolled out data showing they work in non-radiographic axial spondyloarthritis.